Related Experiment Video
Updated: Aug 17, 2026
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
Childhood craniopharyngioma: Vancouver experience
Juliette Hukin1, Johann Visser, Michael Sargent
1Division of Neurology and Oncology, British Columbia Children's Hospital, 4480 Oak St., Vancouver, V6H 3V4, Canada. jhukin@cw.bc.ca
Insights
Childhood craniopharyngioma patients often survive long-term but may experience lasting deficits. A conservative management approach, including intracystic bleomycin, can minimize severe morbidity in pediatric craniopharyngioma care.
Area of Science:
- Pediatric neurosurgery
- Pediatric oncology
- Pediatric endocrinology
Background:
- Craniopharyngioma is a rare brain tumor affecting children.
- Long-term outcomes and management strategies for pediatric craniopharyngioma require further investigation.
Purpose of the Study:
- To present the institutional experience in managing childhood craniopharyngioma.
- To evaluate long-term survival and morbidity in pediatric craniopharyngioma patients.
Main Methods:
- Retrospective review of pediatric craniopharyngioma cases from 1982-2003.
- Systematic neuroimaging review by a neuroradiologist.
- Kaplan-Meier survival analysis for progression-free and overall survival.
Main Results:
- Most children diagnosed with craniopharyngioma achieve long-term survival.
- Survivors frequently experience significant long-term deficits.
- Intracystic bleomycin offers a strategy to delay more aggressive treatments in select cases.
Conclusions:
- Conservative surgical and radiotherapeutic approaches are recommended to minimize morbidity.
- Minimizing interventions known to cause severe morbidity is crucial for improving quality of life.
- Intracystic bleomycin can be a valuable tool in the multidisciplinary management of pediatric craniopharyngioma.
Objective:
To present our institution's experience in the management of childhood craniopharyngioma since 1982.
Methods:
We retrospectively reviewed the records of all children diagnosed with craniopharyngioma at our children's hospital from its opening in 1982 through to 2003. One neuroradiologist systematically reviewed the neuroimaging. Kaplan-Meier curves were used to analyze the progression-free survival and the overall survival from the time of the first definitive intervention.
Conclusions:
Most children diagnosed with craniopharyngioma are long-term survivors. Survivors suffer from multiple deficits in the long term. A conservative surgical and radiotherapeutic approach and avoiding interventions that are known to cause severe morbidity may minimize these. The use of intracystic bleomycin is a strategy that allows the delay of more aggressive therapies in select patients.
